Xingen Zhang

Xingen Zhang

Auto-generated profile, based on publicly available information

Xingen Zhang

Department of Orthopedics, Jiaxing Key Laboratory for Minimally Invasive Surgery in Orthopaedics & Skeletal Regenerative Medicine, Zhejiang Rongjun Hospital, Jiaxing, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2025 in The FASEB Journal
Verified
Journal Article
Open access
MDMuhammad Dilawar
Muhammad Dilawar
XYXuan Yu
Xuan Yu
YJYuanyuan Jin
Yuanyuan Jin
JYJing Yang
Jing Yang
SLSisi Lin
Sisi Lin
GCGUIQIAN CHEN
GUIQIAN CHEN
The skeletal system provides vital importance to support organ development and functions. The Notch signaling pathway possesses well‐established functions in organ development and cellular homeostasis. The Notch signaling pathway comprises five typical ligands ( JAG1 , JAG2, DLL1, DLL3, and DLL4), four receptors ( Notch 1‐4), and four intracellular domains (NICD1‐4). Each component of the Notch signaling pathway has been demonstrated to be fundamental in osteoblast differentiation and bone formation. The dysregulation in the Notch signaling pathway is highly linked with skeletal disorders or diseases at the developmental and postnatal stages. Recent studies have highlighted the importance of the elements of the Notch signaling pathway in the skeletal system, as well as its interaction with signaling, such as Wnt/β‐catenin, BMP, TGF‐β, FGF, autophagy, and hedgehog (Hh) to construct a potential gene regulatory network to orchestrate osteogenesis and ossification. Our review has provided a comprehensive summary of the Notch signaling pathway in the skeletal system, as well as the insights targeting Notch signaling for innovative potential drug discovery targets or therapeutic interventions to treat bone disorders, such as osteoporosis and osteoarthritis. An in‐depth molecular mechanistic strategy to modulate the Notch signaling pathway and its associated signaling pathway will be encouraged for consideration to trigger enhanced therapeutic approaches for bone disorders by defining Notch‐regulating drugs for clinical use.

5 July 2024 in The FASEB Journal
Verified
Journal Article
Open access
RVRexhina Vlashi
Rexhina Vlashi
FSFuju Sun
Fuju Sun
CZChenggong Zheng
Chenggong Zheng
XZXingen Zhang
Xingen Zhang
JLJie Liu
Jie Liu
GCGUIQIAN CHEN
GUIQIAN CHEN
The neurofibromatosis type 2 ( NF2 ) gene, known for encoding the tumor suppressor protein Merlin, is central to the study of tumorigenesis and associated cellular processes. This review comprehensively examines the multifaceted role of NF2 /Merlin, detailing its structural characteristics, functional diversity, and involvement in various signaling pathways such as Wnt/β‐catenin, Hippo, TGF‐β, RTKs, mTOR, Notch, and Hedgehog. These pathways are crucial for cellular growth, proliferation, and differentiation. NF2 mutations are specifically linked to the development of schwannomas, meningiomas, and ependymomas, although the precise mechanisms of tumor formation in these specific cell types remain unclear. Additionally, the review explores Merlin's role in embryogenesis, highlighting the severe developmental defects and embryonic lethality caused by NF2 deficiency. The potential therapeutic strategies targeting these genetic aberrations are also discussed, emphasizing inhibitors of mTOR, HDAC, and VEGF as promising avenues for treatment. This synthesis of current knowledge underscores the necessity for ongoing research to elucidate the detailed mechanisms of NF2 /Merlin and develop effective therapeutic strategies, ultimately aiming to improve the prognosis and quality of life for individuals with NF2 mutations.

8 August 2019 in Developmental Dynamics
Verified
Journal Article
Open access
PDF file
GCGuiqian Chen
Guiqian Chen
YYYifeng Yao
Yifeng Yao
GXGuangtao Xu
Guangtao Xu
XZXingen Zhang
Xingen Zhang
Background The murine calvaria has several membrane bones with different tissue origins (e.g., neural crest-derived frontal bone vs. mesoderm-derived parietal bone). Neural crest-derived frontal bone exhibits superior osteogenic activities and bone regeneration. MicroRNA (miRNA) has been emerged as a crucial regulator during organogenesis and is involved in a range of developmental processes. However, the underlying roles of miRNA regulation in frontal bone and parietal bone is unknown. Results Total of 83 significantly expressed known miRNAs were identified in frontal bones versus parietal bones. The significantly enriched gene ontology and KEGG pathway that were predicted by the enrichment miRNAs were involved in several biological processes (cell differentiation, cell adhesion, and transcription), and multiple osteogenic pathways (e.g., focal adhesion, MAPK, VEGF, Wnt, and insulin signaling pathway. Focal adhesion and insulin signaling pathway were selected for target verification and functional analysis, and several genes were predicted to be targets genes by the differentially expressed miRNAs, and these targets genes were tested with significant expressions. Conclusions Our results revealed a novel pattern of miRNAs in murine calvaria with dual tissue origins, and explorations of these miRNAs will be valuable for the translational studies to enhance osteogenic potential and bone regeneration in the clinic.

6 December 2023 in Reviews in Endocrine and Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
RVRexhina Vlashi
Rexhina Vlashi
XZXingen Zhang
Xingen Zhang
HLHaibo Li
Haibo Li
GCGUIQIAN CHEN
GUIQIAN CHEN

12 March 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
JLJunguang Liao
Junguang Liao
YHYuping Huang
Yuping Huang
FSFuju Sun
Fuju Sun
CZChenggong Zheng
Chenggong Zheng
YYYifeng Yao
Yifeng Yao
GCGUIQIAN CHEN
GUIQIAN CHEN
Skeletal mesenchymal stem cells (MSCs) possess self-renewal capacities and play a leading role in the craniofacial system. However, their engagement in controlling cranial bone development and regeneration remains largely unidentified. Herein, we discovered the neurofibromin 2 (Nf2)-encoded regulator Merlin, demonstrating indispensableness in the craniofacial system. Mice lacking Nf2 in MSCs exhibit malformed cranial bones, diminished proliferation, increased apoptosis, and more severe osteogenesis impairment. Mechanically, we substantiate that Nf2 physically interacts with focal adhesion kinase (FAK) to preferentially mediate Erk1/2 and PI3K catalytic p110 subunit/Akt signaling. Meanwhile, Nf2-FAK disturbance in MSCs results in deficient migration, cytoskeletal organization and focal adhesion dynamics, and develops retarded regeneration of cranial bone defects. Collectively, our findings underscore an unrecognized scaffolding role for Nf2-FAK as upstream element in regulating PI3K/Akt and Erk1/2 action in osteoblasts, and illuminate its essentialness in coordinating cell migration, osteogenic lineage development, cranial bone ossification and regeneration.

23 September 2025 in JCI Insight
Verified
Journal Article
Open access
YHYuping Huang
Yuping Huang
JLJunguang Liao
Junguang Liao
PSPanpan Shen
Panpan Shen
YHYiliang He
Yiliang He
FSFuju Sun
Fuju Sun
GCGUIQIAN CHEN
GUIQIAN CHEN
Cranial neural crest cells (CNCs) play a critical role in craniofacial bone morphogenesis, engaging in intricate interactions with various molecular signals to ensure proper development, yet the molecular scaffolds coordinating these processes remain incompletely defined. Here, we identify neurofibromin 2 ( Nf2 ) as a critical regulator to direct CNC-derived skull morphogenesis. Genetic ablation of Nf2 in murine CNCs causes severe craniofacial anomalies, featuring declined proliferation and increased apoptosis in osteoprogenitors, impaired type I collagen biosynthesis and trafficking, and aberrant osteogenic mineralization. Mechanistically, we uncover that Nf2 serves as a molecular linker that individually interacts with FGF receptor 1 (FGFR1) and Akt through spatially segregated phosphor-sites, and structural modeling and mutagenesis identified Ser10 and Thr230 as essential residues, with Thr230 mutation selectively ablating Akt binding while preserving FGFR1 association. Strikingly, Akt inhibition phenocopied Nf2 deficiency, reducing collagen production and Nf2 phosphorylation, whereas phospho-mimetic Nf2 (T230D) rescued CNC-derived osteogenic defects in Nf2 -mutant animals. Our findings underscore the physiological significance of Nf2 as a phosphorylation-operated scaffold licensing the FGFR1/AKT axis to regulate collagen type I biogenesis and trafficking, ensuring normal CNC-derived osteogenesis and craniofacial bone development, thus exposing the Nf2/FGFR1/AKT signaling axis as a therapeutic target and promising advancements in treatment of craniofacial anomalies.